Physician
Urology
Dr. Carlos A. Vivas, MD
|
|
Give Review
Carlos Vivas is an expert in the field of Urology. He over the years received 2 awards: "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". Carlos Vivas is a published doctor and has 101 publications published. The lastest was: 'Human polyoma virus-associated interstitial nephritis in the allograft kidney.' Carlos Vivas accepts Medicare payments and is listed with Medicare.gov.
Publications
- Long-term results of pediatric Renal transplantation into a dysfunctional lower urinary tract.
- High prevalence of screening-detected prostate Cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey.
- Cadaveric renal transplantation using Kidneys from donors greater than 60 years old.
- The superiority of tacrolimus in Renal transplant recipients -- the Pittsburgh experience.
- The lack of effect of aerobic exercise training on propranolol pharmacokinetics in young and elderly adults.
- Tacrolimus rescue therapy for Renal transplant rejection.
- Tacrolimus in Renal transplantation.
- Combined simultaneous Kidney/bone marrow transplantation.
- Enteric drainage of pancreas transplants revisited.
- Effect of recipient race on waiting time for Renal transplantation at the University of Pittsburgh.
- Posttransplant hypertension in blacks versus nonblacks.
- Inability of effluent hyaluronic acid levels to predict early graft function in clinical Renal transplantation.
- Acyclovir/cytomegalovirus immune globulin combination therapy for CMV prophylaxis in high-risk Renal allograft recipients.
- Combined Kidney/bone marrow transplantation--evidence of augmentation of chimerism.
- Interferon-alpha-induced acute Renal allograft rejection.
- Renal transplantation under FK 506 in African-Americans: early experience.
- Serum cholesterol levels in African Americans after Renal transplantation under FK 506 immunosuppression.
- Posttransplant diabetes mellitus in African Americans after Renal transplantation under FK 506 immunosuppression.
- FK 506 in the management of nephrotic syndrome after Renal transplantation.
- Randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone after Renal transplantation: preliminary report.
- Ganciclovir for invasive cytomegalovirus Infection in renal allograft recipients.
- Pediatric Kidney transplantation at the University of Pittsburgh.
- FK506 in pediatric Kidney transplantation--primary and rescue experience.
- Effect of Chronic noise or water restriction on weight of body and organs in the rat.
- Pediatric urethral reconstruction without proximal diversion.
- Retrograde transurethral balloon dilation of prostate: innovative management of abacterial Chronic prostatitis and prostatodynia.
- Renal transplantation at the University of Pittsburgh: the impact of FK506.
- Renal transplantation under cyclosporine and FK 506 for hemolytic uremic syndrome.
- A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in Renal transplant patients.
- A prospective randomized trial of FK506-based immunosuppression after Renal transplantation.
- A prospective, randomized trial of FK-506 in Renal transplantation--a comparison between double- and triple-drug therapy.
- Improving results of pediatric Renal transplantation.
- Tacrolimus nephrotoxicity after Renal transplantation.
- Pancreas transplantation without antibody therapy.
- Outcome of Kidney transplantation in African-Americans using tacrolimus.
- Acute Renal allograft rejection in patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder.
- Clinical significance of Renal allograft biopsies with "borderline changes," as defined in the Banff Schema.
- Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature.
- Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in Kidney transplant recipients.
- Enteric-drained pancreas transplants monitored by fine-needle aspiration biopsy.
- Pancreas transplantation with enteric drainage under tacrolimus induction therapy.
- A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in Renal transplant recipients.
- Human polyoma virus-associated interstitial nephritis in the allograft Kidney.
- Clinical significance of Renal biopsies showing concurrent acute rejection and tacrolimus-associated tubular vacuolization.
- [Primary cerebral lymphoma with negative SPECT in a patient with AIDS].
- Endocarditis caused by Aspergillus niger: case report.
- A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing Renal transplantation: first report.
- Reducing the length of stay after Kidney transplantation--the intensive outpatient unit.
- Outcome after steroid withdrawal in Renal transplant patients receiving tacrolimus-based immunosuppression.
- Tacrolimus in pediatric Renal transplantation.
- "Suboptimal" Kidney donors: the experience with tacrolimus-based immunosuppression.
- Alopecia as a consequence of tacrolimus therapy.
- A prospective, randomized trial of tacrolimus/prednisone vs tacrolimus/prednisone/mycophenolate mofetil in Renal transplantation: 1-year actuarial follow-up.
- Pediatric Renal transplantation under tacrolimus-based immunosuppression.
- Renal transplantation in recipients over the age of 60: the impact of donor age.
- Posttransplant diabetes in pediatric recipients on tacrolimus.
- Posttransplant lymphoproliferative disorders in adult and pediatric Renal transplant patients receiving tacrolimus-based immunosuppression.
- Outcome of tacrolimus conversion therapy for Renal allograft rejection: 5-year follow-up.
- Tacrolimus-based immunosuppression in pediatric Renal transplantation.
- Epstein-Barr virus-related disorders in children undergoing Renal transplantation with tacrolimus-based immunosuppression.
- Outcome after steroid withdrawal in pediatric Renal transplant patients receiving tacrolimus-based immunosuppression.
- [Chagas Disease: another cause of cerebral mass occurring in patients with acquired immunodeficiency syndrome].
- Renal retransplantation in elderly recipients under tacrolimus-based immunosuppression.
- Biopsy of marginal donor Kidneys: correlation of histologic findings with graft dysfunction.
- Acute Renal allograft rejection with severe tubulitis (Banff 1997 grade IB).
- Cytomegalovirus Infection of the native ureter after liver-kidney transplantation.
- Outcome of Kidney transplantation under tacrolimus-based immunosuppression in elderly patients.
- Initial pleural pressure measurement in spontaneous pneumothorax.
- Outcome after steroid withdrawal in adult Renal transplant patients receiving tacrolimus-based immunosuppression.
- Long-term lipid metabolism in combined Kidney-pancreas transplant recipients under tacrolimus immunosuppression.
- An analysis of early Renal transplant protocol biopsies--the high incidence of subclinical tubulitis.
- Thyroid hormone in the treatment of post-transplant acute tubular necrosis (ATN).
- Labetalol-induced hyperkalemia in Renal transplant recipients.
- Hemorrhagic complications of enoxaparin and aspirin in patients with Kidney transplants.
- Renal allograft rejection with normal renal function in simultaneous Kidney/pancreas recipients: does dissynchronous rejection really exist?
- Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients.
- High-risk donors: expanding donor criteria.
- Long-term results of pancreas transplantation under tacrolius immunosuppression.
- Comparison of azathioprine and mycophenolate mofetil in pancreas transplantation.
- Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients.
- The use of tacrolimus in Renal transplantation.
- Tacrolimus for rescue of refractory Renal allograft rejection.
- Cadaveric Renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up.
- Long-term follow-up of tacrolimus rescue therapy for Renal allograft rejection.
- Five-year experience with tacrolimus rescue for Renal allograft rejection.
- Cadaveric Renal transplantation using donors over 60 years old--5 year follow-up.
- Tacrolimus rescue therapy for Renal allograft rejection--five-year experience.
- FK506 "rescue" for resistant rejection of Renal allografts under primary cyclosporine immunosuppression.
- Highly sensitized patients with delayed graft function: a management protocol.
- Renal transplantation in patients 65 years old or older.
- Therapeutic use of ganciclovir for invasive cytomegalovirus Infection in cadaveric renal allograft recipients.
- Y-U pyloroplasty.
- FK 506 salvage of Renal allografts with ongoing rejection failing cyclosporine immunosuppression.
- Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression.
- Comparison of enteric versus Bladder drainage in pancreas transplantation.
- Kidney transplantation with bone marrow augmentation: five-year outcomes.
- IVIG rescue therapy in Renal transplantation.
- Simultaneous pancreas-Kidney transplantation at the University of Pittsburgh.
- Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression.
- Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in Renal transplant recipients.
Procedures Preformed
- AdRenalectomy
- Cystometry
- Cystourethroscopy and Transurethral Resection of Bladder Neck
- Incontinence Sling Procedure
- View All
Conditions Treated
- Atrophic Vaginitis
- Balanoposthitis
- Bedwetting
- Bladder Atony
- View All
Doctors Specialties
- Urology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- CoreSource
- Coventry Health America PPO
- First Health (Coventry Health Care) PPO
- Gateway Health Plan
- Community Blue PPO
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medical Mutual of Ohio
- Medicare MCR
- Medico
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
- UPMC PPO
- UPMC Health Plan
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
Education
-
Catholic University of Cordoba Faculty of Medicine
Hospital
-
UPMC Passavant
Drug Facts
| NPI NUMBER | 1063519114 | |
| NPPES Provider LastName | VIVAS | |
| NPPES Provider FirstName | CARLOS | |
| NPPES Provider ZIPCode | 152124769 | |
| NPPES Provider State | PA | |
| Specialty Description | Urology | |
| Total Claim Count | 962.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 43.0 | |
| Percent Opioid Claims | 4.47 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1063519114 |
| Last Name Of The Provider | VIVAS |
| First Name Of The Provider | CARLOS |
| View All |
Similar Doctors
|
|
Dr. John C. Lyne, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy D. Srodes, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashutosh V. Kshirsagar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gina M. Rooker, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ralph J. Miller Jr., MD |
|
|
Dr. Lawrence A. Collins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Cole, MD |
|
|
Dr. Nasir B. Chaudry, MD
This Doctor is OpenDoctor Recommended.
|